Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit $16.9M
admin 12th April 2017 Uncategorised 0 Opdivo lung cancer slip took a bite out of Bristol CEO’s bonus, but pay still hit $16.9M
tracy
Wed, 04/12/2017 – 10:14
More: Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit .9M
Source: fierce